MOLECULAR BIOMARKERS AND HISTOLOGICAL PARAMETERS IMAPCT ON SURVIVAL AND RESPONSE TO FIRST- LINE SYSTEMIC THERAPY OF METASTATIC COLORECTAL CANCER PATIENTS. Radiol Oncol 2019, 53 (1).